39.66 USD
↗ 0.71 (1.82%)AT CLOSE (11:59 AM EDT)
Harmony Biosciences Holdings, Inc. Common Stock
HRMYNASDAQ • USD
39.40
↘ 0.26 (0.66%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
39.40
↘ 0.26 (0.66%)
Market: CLOSED
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) trades at $39.64 per share. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest HRMY is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 26, 2026.
Open?$39.74
High?$40.50
Low?$38.87
Prev. Close?$38.95
Volume?745.2K
Avg. Volume?807.7K
VWAP?$39.58
Rel. Volume?0.92x
Bid / Ask
Bid?$38.30 × 200
Ask?$40.50 × 500
Spread?$2.20
Midpoint?$39.40
Valuation & Ratios
Market Cap?2.3B
Shares Out?58.2M
Float?45.5M
Float %?78.5%
P/E Ratio?12.74
P/B Ratio?2.31
EPS?$3.11
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Themes
Employees
293
Market Cap
2.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-08-19
Address
630 W GERMANTOWN PIKE
PLYMOUTH MEETING, PA 19462
Phone: (484) 539-9800
PLYMOUTH MEETING, PA 19462
Phone: (484) 539-9800
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?99
Momentum?75
Short Sent.?65
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.68Safe
Confidence?71%Moderate
Short InterestElevated
Short % of Float?9.10%Elevated
Short Interest?4.1M
Days to Cover?4.8
Free Float45.5M
Avg Daily Volume866.8K
Settlement Date2026-08-14
Financial Health
Current Ratio?3.48Strong
Quick Ratio?3.45Strong
Cash Ratio?2.35Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?12.7CHEAP▾
Peers100
S&P89
P/B?2.31CHEAP▾
Peers100
S&P68
P/S?2.41CHEAP▾
Peers100
S&P59
P/FCF?6.5CHEAP▾
Peers100
S&P97
EV/EBITDA?7.8CHEAP▾
Peers100
S&P91
EV/Sales?1.99CHEAP▾
Peers100
S&P75
Returns & Efficiency
ROE?18.1%STRONG▾
Peers50
S&P62
ROA?13.2%STRONG▾
Peers50
S&P83
Cash Flow & Enterprise
FCF?$354.9M
Enterprise Value?$1.9B
Fundamentals ratios updated end of day